Slider-home

Infectious Diseases and Immunity in Global Health Program

The Infectious Diseases and Immunity in Global Health Program is integrating research in infectious diseases, immunity and global health at the Research Institute of the McGill University Health Centre (RI-MUHC) into work groups with a strong translational focus.

The translational topics are (i) diagnostics, (ii) therapeutics and prevention and (iii) epidemiology and health outcomes. A distinguishing feature of the program are cross-disciplinary research teams encompassing basic biomedical, clinical and health outcomes research that jointly work on novel ways to improve patient well-being and population health in focus diseases.

Program initiatives are well integrated with ongoing research efforts of other groups at McGill University, as well as national and international centres and organizations dedicated to infectious and immune-mediated diseases. This provides the organizational framework for cutting edge research at the front lines of the most pressing global disease threats by program scientists.

IDIGH Calendar

<<  <  January 2021  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
      1  2  3
  4  5  6  7  8  910
11121314151617
18192021222324
25262728293031

Latest IDIGH Publications

  1. Duffy, S. C., Srinivasan, S., Schilling, M. A., Stuber, T., Danchuk, S. N., Michael, J. S., Venkatesan, M., Bansal, N., Maan, S., Jindal, N., Chaudhary, D., Dandapat, P., Katani, R., Chothe, S., Veerasami, M., Robbe-Austerman, S., Juleff, N., Kapur, V. & Behr, M. A.
    (2020)
    .
    Reconsidering Mycobacterium bovis as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance study
    .
    The Lancet. Microbe
    ,
    vol
    .
    1
    ,
    p
    .
    e66-e73
    .
  2. Stallworthy, G., Dias, H. M. & Pai, M.
    (2020)
    .
    Quality of tuberculosis care in the private health sector
    .
    Journal of clinical tuberculosis and other mycobacterial diseases
    ,
    vol
    .
    20
    ,
    p
    .
    100171
    .
  3. Noël, K. C., Papenburg, J., Lacroix, J., Quach, C., O'Donnell, S., Gonzales, M., Willson, D. F., Gilfoyle, E., McNally, J. D., Reynolds, S., Kazzaz, Y., Kawaguchi, A., Sato, M., Kongkiattikul, L., Leteurtre, S., Dubos, F., Karaca, Y., Chiusolo, F., Piva, J., Dendukuri, N., Fontela, P. S. & Canadian Critical Care Trials Group (CCCTG) and the Pediatric Lung Injury and Sepsis Investigators (PALISI) Network.
    (2020)
    .
    International Survey on Determinants of Antibiotic Duration and Discontinuation in Pediatric Critically Ill Patients
    .
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
  4. Saha-Chaudhuri, P., Rabin, C., Tchervenkov, J., Baran, D., Morein, J. & Sapir-Pichhadze, R.
    (2020)
    .
    Predicting Clinical Outcome in Expanded Criteria Donor Kidney Transplantation: A Retrospective Cohort Study
    .
    Canadian journal of kidney health and disease
    ,
    vol
    .
    7
    ,
    p
    .
    2054358120924305
    .
  5. Ladouceur, A., Tessier-Cloutier, B., Clarke, A. E., Ramsey-Goldman, R., Gordon, C., Hansen, J. E. & Bernatsky, S.
    (2020)
    .
    Cancer and Systemic Lupus Erythematosus
    .
    Rheumatic diseases clinics of North America
    ,
    vol
    .
    46
    ,
    p
    .
    533-550
    .
More publications